Abstract B038: Long-term outcomes following surgical resection in a three-center subset of a randomized phase II trial of dose-escalated radiotherapy for borderline resectable and locally advanced pancreatic cancer
Surgical resection following neoadjuvant therapy is associated with prolonged survival in borderline resectable and locally advanced pancreatic cancer (BRPC/LAPC), yet whether this reflects improved local disease control alone or identifies patients with intrinsically favorable disease biology remains uncertain....